Internal Medicine · Fort Myers, FL
NPI
1487748356
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
8991 Daniels Center Dr Ste 105
Fort Myers, FL, 33912
Phone (239) 440-6456
Groups this clinician bills Medicare through
Medicare paid, 2024
$253K
3,021 services
Medicare patients, 2024
1,226
Average age 77
Drug cost, 2024
$2.8M
37,372 prescriptions
Company payments, 2025
$154
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roderick Nassif was code 99232 (hospital e&m - subsequent), 1,111 times for 398 patients. In total Roderick Nassif billed 3,021 services in 25 codes, and Medicare paid $253K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,111 | 398 | $63.98 | $71K |
| 99222 Hospital E&M - Initial | Facility | 433 | 425 | $102.00 | $44K |
| 99233 Hospital E&M - Subsequent | Facility | 385 | 217 | $96.52 | $37K |
| 99223 Hospital E&M - Initial | Facility | 306 | 254 | $136.70 | $42K |
| 99305 SNF E&M | Facility | 293 | 268 | $105.33 | $31K |
| 99238 Hospital Discharge Management | Facility | 174 | 165 | $65.78 | $11K |
| 99308 SNF E&M | Facility | 76 | 67 | $45.44 | $3,453 |
| 99213 Office E&M - Established | Office | 47 | 14 | $61.27 | $2,880 |
| 99231 Hospital E&M - Subsequent | Facility | 34 | 18 | $40.39 | $1,373 |
| 99239 Hospital Discharge Management | Facility | 32 | 32 | $92.59 | $2,963 |
| 99307 SNF E&M | Facility | 32 | 32 | $23.47 | $751 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 29 | 28 | $43.39 | $1,258 |
| 99214 Office E&M - Established | Office | 25 | 12 | $82.92 | $2,073 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 21 | 13 | $33.85 | $711 |
By year: 2022 $246K for 3,200 services; 2023 $349K for 4,206 services; 2024 $253K for 3,021 services.
Medicare prescription drug claims, 2024
In 2024, the drug Roderick Nassif prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,656 prescriptions and refills. In total Roderick Nassif wrote 37,372 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,656 | 1,673 | 273 | $31K |
| Amlodipine Besylate Generic | 1,222 | 1,254 | 205 | $11K |
| Eliquis Apixaban | 1,100 | 1,103 | 121 | $347K |
| Levothyroxine Sodium Generic | 1,036 | 1,069 | 165 | $14K |
| Gabapentin Generic | 964 | 967 | 176 | $22K |
| Tamsulosin Hcl Generic | 838 | 853 | 141 | $17K |
| Pantoprazole Sodium Generic | 755 | 769 | 162 | $12K |
| Metoprolol Tartrate Generic | 717 | 718 | 131 | $7,721 |
| Metoprolol Succinate Generic | 712 | 736 | 139 | $17K |
| Lisinopril Generic | 710 | 722 | 106 | $7,591 |
| Potassium Chloride Generic | 685 | 697 | 137 | $14K |
| Furosemide Generic | 649 | 671 | 131 | $4,134 |
| Xarelto Rivaroxaban | 562 | 566 | 57 | $169K |
| Clopidogrel Clopidogrel Bisulfate | 561 | 567 | 93 | $9,093 |
| Divalproex Sodium Generic | 559 | 559 | 116 | $37K |
Brand drugs: 6,049 claims; generic drugs: 31,269 claims; opioid claims: 754.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roderick Nassif $154 ($154 in general payments such as food, travel and fees) from 1 company. The largest payer was Neurocrine BioSciences, Inc. with $154.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 2 | $154 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.